CompletedNot Applicable

Effect of 12-week FW Programme on Sex Hormone Levels and Risk Factors for MS in Postmenopausal Women

China30 participantsStarted 2022-04-16

Plain-language summary

Postmenopausal women were separated into two groups: one participating in a 12-week fitness walking programe as the fitness walking group, and the other maintaining their regular lifestyle as the control group. The study evaluated alterations in health markers and examined the correlation between metabolic syndrome risk factors and sex hormone levels before and after the intervention.

Who can participate

Age range50 Years – 69 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * (1) Participants were entirely voluntary and capable of completing the full 12-week intervention process. * (2) Participants were postmenopausal women aged between 50 and 69 years. * (3) Participants had been postmenopausal for over 12 months and had not received exogenous estrogen supplementation post-menopause. Exclusion Criteria: * (1) Participants had a history of acute or chronic musculoskeletal disorders, cardiovascular diseases, diabetes, or other conditions that might impact their ability to engage in the intervention. * (2) Participants had recent hormone treatment, anti-inflammatory medication use, or other medications affecting blood indices. * (3) Participants experienced unstable body weight (fluctuations exceeding 2.5 kg) in the past three months. * (4) Participants were concurrently enrolled in other intervention studies or maintained regular exercise routines. * (5) Participants had smoking or alcohol consumption habits.

What they're measuring

Systolic blood pressure (SBP)

Timeframe: At the beginning-at 12 weeks.

Diastolic blood pressure (DBP)

Timeframe: At the beginning-at 12 weeks.

Waist circumference (WC)

Timeframe: At the beginning-at 12 weeks.

Fasting blood glucose (FBG)

Timeframe: At the beginning-at 12 weeks.

Triglycerides (TG)

Timeframe: At the beginning-at 12 weeks.

High-density lipoprotein cholesterol (HDL-C)

Timeframe: At the beginning-at 12 weeks.

Trial details

NCT IDNCT06454032

SponsorBeijing Sport University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-30

View on ClinicalTrials.gov More Postmenopause Women trials

Plain-language summary

Who can participate

Age range50 Years – 69 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Systolic blood pressure (SBP)

Timeframe: At the beginning-at 12 weeks.

Diastolic blood pressure (DBP)

Timeframe: At the beginning-at 12 weeks.

Waist circumference (WC)

Timeframe: At the beginning-at 12 weeks.

Fasting blood glucose (FBG)

Timeframe: At the beginning-at 12 weeks.

Triglycerides (TG)

Timeframe: At the beginning-at 12 weeks.

High-density lipoprotein cholesterol (HDL-C)

Timeframe: At the beginning-at 12 weeks.